Leader in the development and commercialization of a new class of medicines

Corporate

Scientific Advisors: Heart Failure

Mihai Gheorghiade, M.D.
Dr. Gheorghiade is Professor of Medicine and Surgery, Associate Chief of the Division of Cardiology, and Chief of the Cardiology Clinical Service at Northwestern University Feinberg School of Medicine.
Barry H. Greenberg, M.D.
Dr. Greenberg is Professor of Medicine, Director Advanced Heart Failure Program, University of California, San Diego School of Medicine and President of the Heart Failure Society of America from 2006 to 2008.
Douglas L. Mann, M.D.
Dr. Mann is Chief of the Division of Cardiology, and Lewin Chair and Professor of Medicine at Washington University School of Medicine in St. Louis, Cardiologist-in-Chief at Barnes Jewish Hospital, and President of the Heart Failure Society of America.
Bertram Pitt, M.D.
Dr. Pitt is Professor Emeritus at University of Michigan School of Medicine.
Hani N. Sabbah, Ph.D.
Dr. Sabbah is Professor of Medicine at Case Western Reserve University and Wayne State University, and Director of Cardiovascular Research at Henry Ford Health System.
James E. Udelson, M.D.
Dr. Udelson is Chief of the Division of Cardiology at Tufts-New England Medical Center.
Robert L. Engler, M.D.
Dr. Engler is Consultant and Professor Emeritus at University of California, San Diego, Chief Medical Advisor at Cardium Therapeutics, Director of Halozyme Therapeutics, and co-founder of Gensia, Inc. and Collateral Therapeutics.
Raymond J. Lipicky, M.D.
Dr. Lipicky is a Consultant and formerly Director, Division of Cardio-Renal Drug Products at the Food and Drug Administration FDA.